Leiden, the Netherlands, March 13, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host confer ...

FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024Entered into asset purchase agreement ...

Real-time stock price for Manulife Dca Pro Prv Seg Pl Mpip75/75F (MPS4672.CF), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

The stock makes the NASDAQ top percentage gainers list on acquisition news today, currently trading at $8.44, up 3.48, ...

Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors- -Transaction to add near-term commercial opportunity to Jazz's pipeline- -Transaction ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Neurenati Therapeutics Inc., a biotech company focused on rare pediatric diseases, is pleased to announce that the U.S. Food ...

"At Aperture, we bring the universe down to Earth and explore the human condition through thought-provoking stories, mind-bending concepts, and groundbreaking discoveries. Follow us for more ...

Discovered in the metadata for a new DOTA 2 update, it was found that Valve has recently done new work on “HLX”, which is the codename for what is assumed to be Half-Life 3. While this might ...